{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:59:58Z","timestamp":1774443598087,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":120,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.idcr.2019.e00550","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:49:15Z","timestamp":1556898555000},"page":"e00550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pellagra in isoniazid preventive and antiretroviral therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"John Koech","family":"Kipsang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"Choge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Marinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Khayeka-Wandabwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2019.e00550_bib0005","series-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings","author":"World Health Organization","year":"2011"},{"issue":"5","key":"10.1016\/j.idcr.2019.e00550_bib0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/QAD.0000000000000985","article-title":"Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis","volume":"30","author":"Den Boon","year":"2016","journal-title":"AIDS (London, England)"},{"issue":"49","key":"10.1016\/j.idcr.2019.e00550_bib0015","first-page":"361","article-title":"Tuberculosis preventive therapy in HIV-infected individuals: A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis","volume":"68","author":"World Health Organization","year":"1993","journal-title":"Wkly Epidemiol Rec"},{"issue":"14","key":"10.1016\/j.idcr.2019.e00550_bib0020","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.1317660111","article-title":"Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings","volume":"111","author":"Houben","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.idcr.2019.e00550_bib0025","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"issue":"9294","key":"10.1016\/j.idcr.2019.e00550_bib0030","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.idcr.2019.e00550_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2004.01959.x","article-title":"Pellagra: dermatitis, dementia, and diarrhea","volume":"43","author":"Hegyi","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.idcr.2019.e00550_bib0040","series-title":"Vitamin and mineral requirements in human nutrition","author":"World Health Organization","year":"2005"},{"issue":"1","key":"10.1016\/j.idcr.2019.e00550_bib0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1745-6215-15-390","article-title":"The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy\u2013CTN PT006: study protocol for a randomized controlled trial","volume":"15","author":"Lebouch\u00e9","year":"2014","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.idcr.2019.e00550_bib0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/367544","article-title":"Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus","volume":"36","author":"Murray","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2019.e00550_bib0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.idcr.2019.e00550_bib0060","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5694\/mja13.11187","article-title":"An unexpected case of pellagra","volume":"200","author":"Thornton","year":"2014","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.idcr.2019.e00550_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/15569527.2011.574303","article-title":"Isoniazid-induced pellagra","volume":"30","author":"Bilgili","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"10.1016\/j.idcr.2019.e00550_bib0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0253-7613.178821","article-title":"Meyler\u2019s side effects of drugs: the international encyclopedia of adverse drug reactions and interactions","volume":"48","author":"Desai","year":"2016","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"10.1016\/j.idcr.2019.e00550_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2230.1999.00444.x","article-title":"Isoniazid induced pellagra despite pyridoxine supplementation","volume":"24","author":"Darvay","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.idcr.2019.e00550_bib0080","first-page":"1211","article-title":"Drug-induced nutrient deficiencies","volume":"56","author":"Fel\u00edpez","year":"2009","journal-title":"Pediatr Clin"},{"issue":"5","key":"10.1016\/j.idcr.2019.e00550_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1054\/mehy.1999.0908","article-title":"Niacin as a potential AIDS preventive factor","volume":"53","author":"Murray","year":"1999","journal-title":"Med Hypotheses"},{"issue":"7-8","key":"10.1016\/j.idcr.2019.e00550_bib0090","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0899-9007(01)00568-8","article-title":"Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide","volume":"17","author":"Murray","year":"2001","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.idcr.2019.e00550_bib0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mehy.2007.01.029","article-title":"Pellagra: a clue as to why energy failure causes diseases?","volume":"69","author":"Williams","year":"2007","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.idcr.2019.e00550_bib0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-4362.2002.01551.x","article-title":"Pellagra and skin","volume":"41","author":"Karthikeyan","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.idcr.2019.e00550_bib0105","series-title":"Isoniazid-induced pellagra","author":"Griffiths","year":"1976"},{"issue":"8","key":"10.1016\/j.idcr.2019.e00550_bib0110","first-page":"773","article-title":"A pyridoxine-dependent behavioral disorder unmasked by isoniazid","volume":"132","author":"Brenner","year":"1978","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1016\/j.idcr.2019.e00550_bib0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1079\/NRR200486","article-title":"An overview of interactions between micronutrients and of micronutrients with drugs, genes and immune mechanisms","volume":"17","author":"Thurnham","year":"2004","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.idcr.2019.e00550_bib0120","series-title":"Pellagra and its prevention and control in major emergencies","author":"World Health Organization","year":"2000"},{"issue":"5","key":"10.1016\/j.idcr.2019.e00550_bib0125","first-page":"1244","article-title":"An outbreak of pellagra in the Kasese Catchment area, Dowa, Malawi","volume":"96","author":"Matapandeu","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.idcr.2019.e00550_bib0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12889-017-4457-7","article-title":"Challenges and opportunities of optimal breastfeeding in the context of HIV option B+ guidelines","volume":"17","author":"Marinda","year":"2017","journal-title":"BMC Public Health"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T16:22:41Z","timestamp":1721233361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250919300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":26,"alternative-id":["S2214250919300873"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00550","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pellagra in isoniazid preventive and antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00550"}}